Abstract
Bucain, a potent neurotoxin isolated from the venom of the Malayan krait (Bungarus candidus), induces paralysis and death. Its crystal structure has been determined at 2.10 A resolution and based on the molecular topology and hydrophobicity profile is structurally classified as a three-fingered α-neurotoxin possessing a positively charged AChR-binding site.
Keywords: Bucain, crystal structure, Bungarus candidus, three-finger α-neurotoxin
Protein & Peptide Letters
Title: Crystal Structure of Bucain, a Three-Fingered Toxin from the Venom of the Malayan Krait (Bungarus candidus)
Volume: 16 Issue: 12
Author(s): M. T. Murakami, R. M. Kini and R. K. Arni
Affiliation:
Keywords: Bucain, crystal structure, Bungarus candidus, three-finger α-neurotoxin
Abstract: Bucain, a potent neurotoxin isolated from the venom of the Malayan krait (Bungarus candidus), induces paralysis and death. Its crystal structure has been determined at 2.10 A resolution and based on the molecular topology and hydrophobicity profile is structurally classified as a three-fingered α-neurotoxin possessing a positively charged AChR-binding site.
Export Options
About this article
Cite this article as:
Murakami T. M., Kini M. R. and Arni K. R., Crystal Structure of Bucain, a Three-Fingered Toxin from the Venom of the Malayan Krait (Bungarus candidus), Protein & Peptide Letters 2009; 16 (12) . https://dx.doi.org/10.2174/092986609789839304
DOI https://dx.doi.org/10.2174/092986609789839304 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Potential Options to Treat Hypertriglyceridaemia
Current Drug Targets Protein-Tyrosine Phosphatase 1B as a Potential Drug Target for Obesity
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Optimal Sedation for the Ventilation of Critically Ill Patients
Current Respiratory Medicine Reviews Exploring Structure-based Drug Design for the Development of Multitarget Antihypertensives
Letters in Drug Design & Discovery Synergic Study of α-Glucosidase Inhibitory Action of Aloin and its Antioxidant Activity with and without Camel β-Casein and its Peptides
Protein & Peptide Letters Dyslipidemia as a Risk Factor for Erectile Dysfunction
Current Medicinal Chemistry "Heart Failure: Meeting the Challenges of Surveillance and Knowledge Translation in Resource-poor Settings"
Current Cardiology Reviews Gynecomastia in Infants, Children, and Adolescents
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Bioactive Compounds in Diabetic Cardiomyopathy: Current Approaches and Potential Diagnostic and Therapeutic Targets
Cardiovascular & Hematological Agents in Medicinal Chemistry Enzymatic Vitreolysis
Current Diabetes Reviews The Etiology of Hypertension in the Metabolic Syndrome Part Four: The Systemic Perspective – The Role of the Neuroendocrine and Immune Systems,and the Challenge of Integration
Current Vascular Pharmacology Pathogenesis, Clinical Manifestation, Diagnosis, Pathological Findings, Treatment Options, Preventive Measures, and Risk Factors of COVID-19
Coronaviruses α-Glucosidase Inhibition, Antioxidant and Docking Studies of Hydroxycoumarins and their Mono and Bis O-alkylated/acetylated Analogs
Letters in Drug Design & Discovery Adiposity and the Gut - The Role of Gut Hormones
Current Nutrition & Food Science Methacholin Provocation Test in COPD and Healthy Smokers
Current Respiratory Medicine Reviews Magnetic Resonance Imaging Findings of Sixth Cranial Nerve Palsies in Patients Presenting with Diplopia
Current Medical Imaging Atherosclerotic Coronary Heart Disease Epidemiology, Classification and Management
Cardiovascular & Hematological Disorders-Drug Targets Targeting Inflammation in Primary Cardiovascular Prevention
Current Pharmaceutical Design Role of Angiotensin II in the Development of Nephropathy and Podocytopathy of Diabetes
Current Diabetes Reviews Patients with Prehypertension - Do we have Enough Evidence to Treat them?
Current Vascular Pharmacology